Chapter 3 Calcium-Sensing Receptor and Associated Diseases

Progress in Molecular Biology and Translational Science

Volumn 89, Issue C, 2009, Pages 31-95

  Hendy, Geoffrey N ^a   Guarnieri, Vito ^b   Canaff, Lucie ^a  

^a MCGILL UNIVERSITY   (Canada)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Allosteric modifiers; Autoimmunity; Autosomal dominant hypocalcemia; Calcilytics; Calcimimetics; Calcium sensing receptor; Familial (benign) hypocalciuric hypercalcemia; Neonatal severe hyperparathyroidism; Parathyroid hormone

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; PROTEIN KINASE C;

ALLOSTERISM; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DOWN REGULATION; GENERAL ASPECTS OF DISEASE; GENETICS; HOMEOSTASIS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; ANIMALS; CALCIUM; DISEASE; DOWN-REGULATION; HOMEOSTASIS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN KINASE C; RECEPTORS, CALCIUM-SENSING; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 77957765625     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)89003-0     Document Type: Review

References (375)

1. 2+-sensing receptor from bovine parathyroid. Nature 366 (1993) 575-580
2. Brown E.M. Four parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56 (1983) 572-581
3. Garrett J.E., Tamir H., Kifor O., Simin R.T., Rogers K.V., Mithal A., et al. Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 136 (1995) 5202-5211
4. Friechel M., Zink-Lorentz A., Holloschi A., Hafner M., Flocerzi V., and Raue F. Expression of a calcium-sensing receptor in a human medullary cell line and its contribution to calcitonin secretion. Endocrinology 137 (1996) 3842-3848
5. Fudge N.J., and Kovacs C.S. Physiological studies in heterozygous calcium-sensing receptor (CaSR) gene-ablated mice confirm that CaSR regulates calcitonin release in vivo. BMC Physiol 4 (2004) 5
6. VanHouten J.N., Neville M.C., and Wysolmerski J.J. The calcium-sensing receptor regulates plasma membrane calcium adenosine triphosphatase isoform 2 activity in mammary epithelial cells: mechanism for calcium-regulated calcium transport into milk. Endocrinology 148 (2002) 5943-5954
7. Brown E.M., and Lian J.B. New insights in bone biology: unmasking skeletal effects of the extracellular calcium-sensing receptor. Sci Signal 1 (2008) pe40
8. Chang W., Tu C., Chen T.H., Bikle D., and Shoback D. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1 (2008) ra1
9. Yamaguchi T. The calcium-sensing receptor in bone. J Bone Miner Metab 26 (2008) 301-311
10. Mentaverri R., Yano S., Chattopadhyay N., Petit L., Kifor O., Kamel S., et al. The calcium-sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 20 (2006) 2562-2564
11. Cheng L., Wang D., Palmer G., Caverzasio J., Canaff L., Hendy G.N., et al. Regulation of expression of the calcium-sensing receptor (CASR) and sodium-dependent phosphate transporter (Glvr-1) in differentiating chondrocytes in vivo. Bone 23S (1998) SA114
12. Chang W., Tu C., Chen T.H., Komuves L., Oda Y., Pratt S.A., et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140 (1999) 5883-5893
13. 2+-sensing receptor promotes loss of cancellous bone. Endocrinology 148 (2007) 3156-3163
14. Kovacs C.S., Ho-Pao C.L., Hunzelman J.L., Lanske B., Fox J., Seidman J.G., et al. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. J Clin Invest 101 (1998) 2812-2820
15. Ruat M., Molliver M.E., Snowman A.M., and Snyder S.H. Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA 92 (1995) 3161-3165
16. Oda Y., Tu C.L., Pillai S., and Bikle D. The calcium-sensing receptor and its alternatively spliced form in keratinocyte differentiation. J Biol Chem 273 (1998) 23344-23352
17. Molostvov G., James S., Fletcher S., Bennett J., Lehnert H., Bland R., et al. Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 293 (2007) F946-F955
18. Adams G.B., Chabner K.T., Alley I.R., Olson D.P., Szczepiorkowski Z.M., Poznansky M.C., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439 (2006) 599-603
19. Ray J.M., Squires P.E., Curtis S.B., Meloche M.R., and Buchan A.M. Expression of the calcium-sensing receptor on human antral gastrin cells in culture. J Clin Invest 99 (1997) 2328-2333
20. Geibel J., Sritharan K., Geibel R., Persing J.S., Seeher A., Roepke T.K., et al. Calcium-sensing receptor abrogates secretagogue-induced increases in intestinal net fluid secretion by enhancing cyclic nucleotide destruction. Proc Natl Acad Sci USA 103 (2006) 9390-9397
21. Cheng S.X., Okuda M., Hall A.E., Geibel J.P., and Hebert S.C. Expression of calcium-sensing receptor in rat colonic epithelium: evidence for modulation of fluid secretion. Am J Physiol Gastrointest Liver Physiol 283 (2001) G240-G250
22. Canaff L., Petit J.-L., Kisiel M., Watson P.H., Gascon-Barré M., and Hendy G.N. Extracellular calcium-sensing receptor is expressed in rat hepatocytes: coupling to intracellular calcium mobilization and stimulation of bile flow. J Biol Chem 276 (2001) 4070-4079
23. 2+ (polyvalent cation)-sensing receptor in rat pancreas. J Biol Chem 274 (1999) 20561-20568
24. Brown E.M., and MacLeod R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81 (2001) 239-297
25. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 (1993) 1297-1303
26. Pollak M.R., Chou Y.H., Marx S.J., Steinmann B., Cole D.EC., Brandi M., et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93 (1994) 1108-1112
27. Brown E.M. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab 3 (2007) 122-133
28. 2+-sensing receptor gene mutation. Nat Genet 8 (1994) 303-307
29. Finegold D.N., Armitage M.M., Galiani M., Matise T.C., Pandian M.R., Perry Y.M., et al. Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. J Pediatr Res 36 (1994) 414-417
30. Perry Y.M., Finegold D.N., Armitage M.M., and Ferrell R.E. Missense mutation in the Ca-sensing receptor gene causes familial autosomal dominant hypoparathyroidism. Am J Hum Genet Suppl. 55 (1994) A17, p 79
31. Pearce S.HS., Williamson C., Kifor O., Bai M., Coulthard M.G., Davies M., et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335 (1996) 1115-1122
32. Lienhardt A., Bai M., Lagarde J.-P., Rigaude M., Zhang Z., Jiang Y., et al. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 86 (2001) 5313-5323
33. Brauner-Osborne H., Wellendorph P., and Jensen A.A. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr Drug Targets 8 (2007) 169-184
34. Janicic N., Soliman E., Pausova Z., Seldin M.F., Riviere M., Szpirer J., et al. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome16. Mamm Genome 6 (1995) 798-801
35. Yun F.HJ., Wong B.YL., Chase M., Shuen A.Y., Canaff L., Thongthai K., et al. Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics. Clin Biochem 40 (2007) 551-561
36. Garrett J.E., Capuano I.V., Hammerland L.G., Hung B.C., Brown E.M., Hebert S.C., et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270 (1995) 12919-12925
37. 2+-sensing receptor cDNA from human kidney. Biochem Biophys Res Commun 214 (1995) 524-529
38. Chikatsu N., Fukumoto S., Takeuchi Y., Suzawa M., Obara T., Matsumoto T., et al. Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. J Biol Chem 275 (2000) 7553-7557
39. Canaff L., and Hendy G.N. Human calcium-sensing receptor gene: vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1, 25-dihydroxyvitamin D. J Biol Chem 277 (2002) 30337-30350
40. Canaff L., and Hendy G.N. Calcium-sensing receptor gene transcription is upregulated by the proinflammatory cytokine, interleukin-1beta: role of the NF-kappaB pathway and kappaB elements. J Biol Chem 280 (2005) 14177-14188
41. Canaff L., Zhou X., Mosesova I., Cole D.EC., and Hendy G.N. Glial cells missing-2 transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism. Hum Mutat 30 (2009) 85-92
42. Canaff L., Zhou X., and Hendy G.N. The proinflammatory cytokine, interleukin-6, upregulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J Biol Chem 283 (2008) 13586-13600
43. Goldsmith P.K., Fan G.F., Ray K., Shiloach J., McPhie P., Rogers K.V., et al. Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J Biol Chem 274 (1999) 11303-11309
44. Pidasheva S., Canaff L., Simonds W.F., Marx S.J., and Hendy G.N. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia. Hum Mol Genet 14 (2005) 1679-1690
45. Hu J., and Spiegel A.M. Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators. J Cell Mol Med 11 (2007) 908-922
46. Bai M. Structure-function relationship of the extracellular calcium-sensing receptor. Cell Calcium 35 (2004) 197-207
47. Emanuel R.L., Adler G.K., Kifor O., Quinn S.J., Fuller F., Krapcho K., et al. Calcium-sensing receptor expression and regulation by extracellular calcium in the AtT-20 pituitary cell line. Mol Endocrinol 10 (1996) 555-565
48. Mamillapalli R., VanHouten J., Zawalich W., and Wysolmerski J. Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J Biol Chem 283 (2008) 24435-24447
49. Ward D.T. Calcium receptor-mediated intracellular signaling. Cell Calcium 35 (2004) 217-228
50. 2+-sensing receptor: a target for polyamines. Am J Physiol 273 (1997) C1315-C1323
51. Ye C., Ho-Pao C.L., Kanazirska M., Quinn S.J., Rogers K., Seidman C.E., et al. Amyloid-beta proteins activate Ca(2+)-permeable channels through calcium-sensing receptors. J Neurosci Res 47 (1997) 547-554
52. Ward D.T., Maldonado-Perez D., Hollins L., and Riccardi D. Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor. J Am Soc Nephrol 16 (2005) 1236-1244
53. Brauner-Osborne H., Jensen A.A., Sheppard P.O., O'Hara P., and Krogsgaard-Larsen P. The agonist binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 274 (1999) 18382-18386
54. Quinn S.J., Kifor O., Trivedi S., Diaz R., Vassilev P., and Brown E.M. Sodium and ionic strength sensing by the calcium receptor. J Biol Chem 273 (1998) 19579-19586
55. Quinn S.J., Bai M., and Brown E.M. pH sensing by the calcium-sensing receptor. J Biol Chem 279 (2004) 37241-37249
56. 2+-sensing receptor. Proc Natl Acad Sci USA 97 (2000) 4814-4819
57. Conigrave A.D., Mun H.C., Delbridge L., Quinn S.J., Wilkinson M., and Brown E.M. l-Amino acids regulate parathyroid hormone secretion. J Biol Chem 279 (2004) 38151-38159
58. Wellendorph P., and Brauner-Osborne H. Molecular basis for amino acid sensing by family C G-protein-coupled receptors. Brit J Pharmacol 156 (2009) 869-884
59. Conigrave A.D., Brown E.M., and Rizzoli R. Dietary protein and bone health: roles of amino acid-sensing receptors in the control of calcium metabolism and bone homeostasis. Annu Rev Nutr 28 (2008) 131-155
60. Nemeth E.F., and Fox J. Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism. Trends Endocrinol Metab 10 (1999) 66-71
61. Jensen A.A., and Brauner-Osborne H. Allosteric modulation of the calcium-sensing receptor. Curr Neuropharmacol 5 (2007) 180-186
62. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 53 (1998) 1083-1088
63. Nemeth E.F., Steffey M.E., Hammerland L.G., Hung B.CP., Van Wagenen B.C., DelMar E.G., et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95 (1998) 4040-4045
64. Nemeth E.F., Heaton W.H., Miller M., Fox J., Balandrin M.F., Van Wagenen B.C., et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 308 (2004) 627-635
65. Dauban P., Ferry S., Faure H., Ruat M., and Dodd R.H. N1-Arylsulfonyl-N2-(1-aryl)ethyl-3-phenylpropane-1, 2-diamines as novel calcimimetics acting on the calcium sensing receptor. Bioorg Med Chem Lett 10 (2000) 2001-2004
66. Kessler A., Faure H., Petrel C., Ruat M., Dauban P., and Dodd R.H. N2-Benzyl-N1-[1-(1-naphthyl)ethyl]-3-phenylpropane-1, 2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor. Bioorg Med Chem Lett 14 (2004) 3345-3349
67. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 299 (2001) 323-331
68. Kessler A., Faure H., Petrel C., Rognan D., Césario M., Ruat M., et al. N1-Benzoyl-N2-[1-(-naphthyl)-trans-1, 2-diaminocyclohexanes, development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity. J Med Chem 49 (2006) 5119-5128
69. Arey B.J., Seethala R., Ma Z., Fura A., Morin J., Swartz J., et al. A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo. Endocrinology 146 (2005) 2015-2022
70. Gowen M., Stroup G.B., Doods R.A., James I.E., Vatta B.J., Smith B.R., et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 105 (2000) 1595-1604
71. Bai M., Quinn S., Trivedi S., Kifor O., Pearce S.HS., Pollak M.R., et al. Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem 271 (1996) 19537-19545
72. Pearce S.HS., Bai M., Quinn S.J., Kifor O., Brown E.M., and Thakker R.V. Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 98 (1996) 1860-1866
73. Bai M., Janicic N., Trivedi S., Quinn S.J., Cole D.EC., Brown E.M., et al. Markedly reduced activity of a mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest 99 (1997) 1917-1925
74. Hauache O.M. Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Braz J Med Biol Res 34 (2001) 577-584
75. D'Souza-Li L. The calcium-sensing receptor and related diseases. Arq Bras Endocrinol Metabol 50 (2006) 628-639
76. 2+ receptor is essential for its expression at the cell surface. Endocrinology 138 (1997) 1916-1922
77. Ray K., Clapp P., Goldsmith P.K., and Spiegel A.M. Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction. J Biol Chem 273 (1998) 34558-34567
78. O'Hara P.J., Sheppard P.O., Thogersen H., Venezia D., Haldeman B.A., McGrane V., et al. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron 11 (1993) 41-52
79. Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamaoto M., Kumasaka T., et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407 (2000) 971-977
80. 3+. Proc Natl Acad Sci USA 99 (2002) 2660-2665
81. Zajickova K., Vrbikova J., Canaff L., Pawelek P.D., Goltzman D., and Hendy G.N. Identification and functional characterization of a novel mutation in the calcium-sensing receptor in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status. J Clin Endocrinol Metab 92 (2007) 2616-2623
82. 2+ receptor extracellular domain. Analysis of function of lobe 1 loop deletion mutants. J Biol Chem 276 (2001) 32145-32151
83. 2+ receptor activation. Endocrine 13 (2000) 63-70
84. 2+ receptor cysteine-rich domain. Analysis of function of mutant and chimeric receptors. J Biol Chem 275 (2000) 16382-16389
85. Bai M., Trivedi S., and Brown E.M. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 273 (1998) 23605-23610
86. Ward D.T., Brown E.M., and Harris H.W. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J Biol Chem 273 (1998) 14476-14483
87. Ray K., Hauschild B.C., Steinbach P.J., Goldsmith P.K., Hauache O., and Spiegel A.M. Identification of the cysteine residues in the amino-terminal extracellular domain of the human Ca(2+) receptor critical for dimerization. Implications for function of monomeric Ca(2+) receptor. J Biol Chem 274 (1999) 27642-27650
88. Zhang Z., Sun S., Quinn S.J., Brown E.M., and Bai M. The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J Biol Chem 276 (2001) 5316-5322
89. Jiang Y., Minet E., Zhang Z., Silver P.A., and Bai M. Modulation of interprotomer relationships is important for activation of dimeric calcium-sensing receptor. J Biol Chem 279 (2004) 14147-14156
90. 2+ receptor: effects on cell surface expression, dimerization and signal transduction. FEBS Lett 436 (1998) 353-356
91. Jensen A.A., Hansen J.L., Sheikh S.P., and Brauner-Osborne H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). Eur J Biochem 269 (2002) 5076-5087
92. Pidasheva S., Grant M., Canaff L., Ercan O., Kumar U., and Hendy G.N. The calcium-sensing receptor (CASR) dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of novel CASR mutations causing familial hypocalciuric hypercalcemia. Hum Mol Genet 15 (2006) 2200-2209
93. 2+ binding pocket within the Venus Flytrap Module of the human calcium-sensing receptor. J Biol Chem 280 (2005) 37917-37923
94. 2+-sensing receptor. J Biol Chem 282 (2007) 19000-19010
95. 2+response. Biochemistry 48 (2009) 388-398
96. Kniazeff J., Bessis A.S., Maurel D., Ansanay H., Prezeau L., and Pin J.P. Closed states of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol 11 (2004) 706-713
97. Muto T., Tsuchiya D., Morikawa K., and Jingami H. Structures of the extracellular regions of the group II/II metabotropic glutamate receptors. Proc Natl Acad Sci USA 104 (2007) 3759-3764
98. 2+ receptor. J Bone Miner Res 22 (2007) 601-608
99. 2+ receptor are not linked by disulfide bonds. J Biol Chem 276 (2001) 6901-6904
100. Ray K., Adipetro K.A., Chen C., and Northup J.K. Elucidation of the role of peptide linker in calcium-sensing receptor activation process. J Biol Chem 282 (2007) 5310-5317
101. 2+ and a positive allosteric modulator. J Biol Chem 277 (2002) 46622-46631
102. 2+ receptor in cell surface expression and receptor activation processes. Endocrinology 145 (2004) 3892-3903
103. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
104. 2+. J Biol Chem 280 (2005) 37013-37020
105. 2+-sensing receptor. J Biol Chem 278 (2003) 49487-49494
106. 2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem 279 (2004) 18990-18997
107. Miedlich S.U., Gama L., Seuwen K., Wolf R.M., and Breitwieser G.E. Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site. J Biol Chem 279 (2004) 7254-7263
108. 2+ receptor conversts a negative allosteric modulator into a positive allosteric modulator. J Biol Chem 281 (2006) 21558-21565
109. 2+-sensing receptor: implications for its structure and function. Trends Endocrinol Metab 14 (2003) 282-288
110. 2+. J Biol Chem 280 (2005) 5113-5120
111. 2+-sensing receptor mediate efficient coupling to phospholipase C. J Biol Chem 275 (2000) 19955-19963
112. Ray K., Fan G.F., Goldsmith P.K., and Spiegel A.M. The carboxyl terminus of the human calcium receptor: requirements for cell-surface expression and signal transduction. J Biol Chem 272 (1997) 31355-31361
113. 2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation. J Biol Chem 276 (2001) 44129-44136
114. Pi M., Oakley R.H., Gesty-Palmer D., Cruickshank R.D., Spurney R.F., Luttrel L.M., et al. β arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization. Mol Endocrinol 19 (2005) 1078-1087
115. Lorenz S., Frenzel R., Paschke R., Breitweiser G.E., and Miedlich S.U. Functional desensitization of the extracellular calcium-sensing receptor is regulated via distinct mechanisms: role of G protein-coupled receptor kinases, protein kinase C and β-arrestins. Endocrinology 148 (2007) 2398-2404
116. 2+ store release. J Biol Chem 273 (1998) 21267-21275
117. 2+o-sensing receptor (CaR) modulates functional interaction of G proteins with the CaR cytoplasmic tail. J Biol Chem 277 (2002) 50543-50549
118. Bouschet T., Martin S., and Henley J.M. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 118 (2005) 4709-4720
119. Cetani F., Pardi E., Borsari S., Tonacchera M., Morabito E., Pinchera A., et al. Two Italian kindreds with familial hypocalciuric hypercalcemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation. Clin Endocrinol 58 (2003) 199-206 Erratum. Clin Endocrinol 58, 671
120. Cetani F., Monica L., Cervia D., Borsari S., Cianferotti L., Pardi E., et al. Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia. Eur J Endocrinol 160 (2009) 481-489
121. Huang Y., Niwa J., Sobue G., and Breitweiser G.E. Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin. J Biol Chem 281 (2006) 11610-11617
122. Huang Y., and Breitwieser G.E. Rescue of calcium-sensing receptor mutants by allosteric modulators reveals a conformational checkpoint in receptor biogenesis. J Biol Chem 282 (2007) 9517-9525
123. Rus R., Haag C., Bumke-Vogt C., Bahr V., Mayr B., Mohlig M., et al. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS-R-568 improves signal transduction of mutant receptors. J Clin Endocrinol Metab 93 (2008) 4797-4803
124. White E., McKenna J., Cavanaugh A., and Breitwieser G.E. Pharmacochaperone-mediated rescue of calcium-sensing receptor loss-of-function mutants. Mol Endocrinol 23 (2009) 1115-1123
125. Hofer A.M., and Brown E.M. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4 (2003) 530-538
126. Breitweiser G.E., and Gama L. Calcium-sensing receptor activation induces intracellular calcium oscillations. Am J Physiol Cell Physiol 280 (2001) C1412-C1421
127. 2+-sensing receptor. Am J Physiol Cell Physiol 282 (2002) C1414-C1422
128. 2+-sensing receptor. J Cell Sci 116 (2003) 1527-1538
129. 2+-sensing receptor. Mol Endocrinol 21 (2007) 274-280
130. Pi M., Chen L., Huang M.Z., Luo Q., and Quarles L.D. Parathyroid-specific interaction of the calcium-sensing receptor and Gq. Kidney Int 74 (2008) 1548-1556
131. 2, and D in bovine parathyroid and CaR-transfected human embryonic kidney cells. J Bone Miner Res 12 (1997) 715-725
132. Kifor O., Diaz R., Butters R., Kifor I., and Brown E.M. The calcium-sensing receptor is located in caveolin-rich plasma membrane domains of bovine parathyroid glands. J Biol Chem 273 (1998) 21708-21713
133. Hjalm G., MacLeod R.J., Kifor O., Chattopadhyay N., and Brown E.M. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, and interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 276 (2001) 34880-34887
134. Awata H., Huang C., Handlogten M.E., and Miller R.T. Interaction of the calcium-sensing receptor and filamin, a protein scaffolding protein. J Biol Chem 276 (2001) 34871-34879
135. Pi M., Spurney R.F., Tu Q., Hinson T., and Quarles L.D. Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotde exchange factor. Endocrinology 143 (2002) 3830-3838
136. Huang C., and Miller R.T. The calcium-sensing receptor and its interacting proteins. J Cell Mol Med 11 (2007) 923-934
137. Zhang M., and Breitwieser G.E. High affinity interaction with filamin A protects against calcium-sensing receptor degradation. J Biol Chem 280 (2005) 11140-11146
138. 2+ and channel blockers. Am J Physiol 269 (1995) E864-E877
139. 2+-sensing receptor activate nonselective cation channels in HEK293 cells stably transfected with the human CaR. Biochem Biophys Res Commun 226 (1996) 572-579
140. Chen C.J., Barnett J.V., Congo D.A., and Brown E.M. Divalent cations suppress 3′,5′-adenosine monophosphate accumulation by stimulating a pertussis toxin-sensitive guanine nucleotide-binding protein in cultured bovine parathyroid cells. Endocrinology 124 (1989) 233-239
141. Kifor O., MacLeod R.J., Diaz R., Bai M., Yamaguchi T., Yao T., et al. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280 (2001) F291-F302
142. Corbetta S., Lania A., Filopanti M., Vicentini L., Ballaré E., and Spada A. Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J Clin Endocrinol Metab 87 (2002) 2201-2205
143. 2 action and arachidonic acid metabolism in calcium-mediated parathyroid hormone secretion. Endocrinology 130 (1992) 1339-1344
144. Bourdeau A., Moutahir M., Souberbielle J.C., Bonnet P., Herviaux P., Sachs C., et al. Effects of lipoxygenase products of arachidonate metabolism on parathyroid hormone secretion. Endocrinology 135 (1994) 1109-1112
145. Quinn S.J., Kifor O., Kifor I., Butters Jr. R.R., and Brown E.M. Role of the cytoskeleton in extracellular calcium-regulated PTH release. Biochem Biophys Res Commun 354 (2007) 8-13
146. Kifor O., Kifor I., Moore Jr. F.D., Butters Jr. R.R., and Brown E.M. m-Calpain colocalizes with the calcium-sensing receptor (CaR) in caveolae in parathyroid cells and participates in degradation of the CaR. J Biol Chem 278 (2003) 31167-31176
147. Brookman J.J., Farrow S.M., Nicholson L., O'Riordan J.LH., and Hendy G.N. Regulation by calcium of parathyroid hormone mRNA in cultured parathyroid tissue. J Bone Miner Res 6 (1987) 529-537
148. Levi R., Ben-Dov I.Z., Lavi-Moshayoff V., Dinur M., Martin D., Naveh-Many T., et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol 17 (2006) 107-112
149. Ho C., Conner D.A., Pollak M.R., Ladd D.J., Kifor O., Warren H.B., et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11 (1995) 389-394
150. Wada M., Ishii H., Furuya Y., Fox J., Nemeth E.F., and Nagano N. NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int 53 (1998) 448-453
151. Colloton M., Shatzen E., Miller G., StehmanpBreen C., Wada M., Lacey D., et al. Cinacalcet Hcl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 67 (2005) 467-476
152. Panda D.K., Miao D., Bolivar I., Li J., Juo R., Hendy G.N., et al. Inactivation of the 25-hydroxyvitamin D-1-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279 (2004) 16754-16766
153. Friedman P.A., and Gesek F.A. Cellular calcium transport in renal epithelia: measurement, mechanisms, and regulation. Physiol Rev 75 (1995) 429-471
154. 2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol 274 (1998) F611-F622
155. Weisinger J.R., Favus M.J., Langman C.B., and Bushinsky D.A. Regulation of 1, 25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. J Bone Miner Res 4 (1989) 929-935
156. Quamme G.A., and de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Front Biosci 5 (2000) D694-D711
157. + channels in the TAL. Am J Physiol 271 (1996) C103-C111
158. Ba J., and Friedman P.A. Calcium-sensing receptor regulation of renal mineral ion transport. Cell Calcium 35 (2004) 229-237
159. 2+ channels in kidney disease. Adv Chronic Kidney Dis 13 (2006) 110-117
160. Huang C., and Miller R.T. Regulation of renal ion transport by the calcium-sensing receptor: an update. Curr Opin Nephrol Hypertens 16 (2007) 437-443
161. 28k gene expression in chick kidney cells. Endocrinology 124 (1989) 1582-1584
162. 2+-sensing in mouse distal convoluted tubule cells. Kidney Int 53 (1998) 583-592
163. 2+ uptake in mouse distal convoluted tubule cells. Am J Physiol 275 (1998) F353-F360
164. Jackson C.E., and Boonstra C. Hereditary hypercalcemia and parathyroid hyperplasia without definite hyperparathyroidism. J Lab Clin Med 68 (1966) 883 Abs 862
165. Foley Jr. T.P., Harrison H.C., Arnaud C.D., and Harrison H.E. Familial benign hypercalcemia. J Pediatr 81 (1972) 1060-1067
166. Law Jr. W.M., and Heath III H. Familial benign hypercalcemia (hypocalciuric hypercalcemia): clinical and pathogenetic stucy of 21 families. Ann Intern Med 102 (1985) 511-519
167. Marx S.J., Attie M.F., Levine M.A., Spiegel A.M., Downs R.WJ., and Lasker R.D. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features of fifteen families. Medicine (Baltimore) 60 (1981) 397-412
168. Heath III H. Familial benign hypercalcemia, a troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin N Am 18 (1989) 723-740
169. Kristiansen J.H., Rodbro P., Christiansen C., Johansen J., and Jensen J.T. Familial hypocalciuric hypercalcemia III: Bone mineral metabolism. Clin Endocrinl (Oxf) 26 (1987) 713-716
170. Christensen S.E., Nissen P.H., Vestergaard P., Heickendorff L., Rejnmark L., Brixen K., et al. Skeletal consequences of familiar hypocalciuric hypercalcemia versus primary hyperparathyroidism. Clin Endocrinol (Oxf) (2009) Epub ahead of print
171. Davies M., Klimiuk P.S., Adams P.H., Lumb G.A., Large D.M., and Anderson D.C. Familial hypocalciuric hypercalcemia and acute pancraetitis. Br Med J 282 (1981) 1023-1025
172. Wang D., Canaff L., Davidson D., Corluka A., Liu H., Hendy G.N., et al. Alterations in the sensing and transport of phosphate and calcium by differentiating chondrocytes. J Biol Chem 276 (2001) 33995-34005
173. Marx S.J., Spiegel A.M., Brown E.M., Koehler J.O., Gardner D.G., Brennan M.F., et al. Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med 65 (1978) 235-242
174. Auwerx J., Demedts M., and Bouillon R. Altered parathyroid set point to calcium in familial hypocalciuric hypercalcemia. Acta Endocrinol 106 (1984) 215-218
175. Khosla S., Ebeling P.R., Firek A.F., Burritt M.M., Kao P.C., and Heath III H. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76 (1993) 715-720
176. Gunn I., and Wallace J. Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcemia. Ann Clin Biochem 29 (1992) 52-58
177. Paterson C.R., and Gunn A. Familial benign hypercalcemia. Lancet 1 (1981) 61-63
178. Law Jr. W.M., Carney J.A., and Heath III H. Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia). Am J Med 76 (1984) 1021-1026
179. Thogeirsson U., Costa J., and Marx S.J. The parathyroid glands in familial benign hypocalciuric hypercalcemia. Hum Pathol 12 (1981) 229-237
180. Attie M.F., Gill Jr. J., Stock J.L., Spiegel A.M., Downs Jr. R.W., Levine M., et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 72 (1983) 667-676
181. Davies M., Adams P.H., Lumb G.A., Berry J., and Loveridge N. Familial hypocalciuric hypercalcemia: evidence for continued enhanced renal tubular reabsorption of calcium following total parathyroidectomy. Acta Endocrinol (Copenhagen) 106 (1984) 499-504
182. Menko F.H., Bijvoet O.LM., Fronen J.LHH., Sandler L.M., Adami S., O'Riordan J.LH., et al. Familial benign hypercalcemia: study of a large family. Q J Med 206 (1983) 120-140
183. Pasieka J., Anderson M., and Hanley D. Familial benign hypercalcemia: hypercalciuria and hypocalciuria in affected members of a small kindred. Clin Endocrinol 33 (1990) 429-433
184. Pearce S.HS., Wooding C., Davies M., Tollefsen S.E., Whyte M.P., and Thakker R.V. Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol 45 (1996) 675-680
185. Carling T., Szabo E., Bai M., Ridefelt P., Westin G., Gustavsson P., et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85 (2000) 2042-2047
186. Marx S.J., Attie M.F., Stock J.L., Spiegel A.M., and Levine M.A. Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 52 (1981) 736-740
187. Sands J.M., Naruse M., Baum M., Jo I., Hebert S.C., Brown E.M., et al. Apical extracellular calcium/polyvalent cation sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99 (1997) 1399-1405
188. Pratt E., Geren B., and Neuhauser E. Hypercalcemia and idiopathic hyperplasia of the parathyroid glands in an infant. J Pediatr (St Louis) 30 (1947) 388-399
189. Hillman D.A., Scriver C.R., Pedvis S., and Shragovitch I. Neonatal familial primary hyperparathyroidism. N Engl J Med 270 (1964) 810-811
190. Marx S.J., Attie M.F., Spiegel A.M., Levine M.A., Lasker R.D., and Fox M. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med 306 (1982) 257-264
191. Marx S.J., Fraser D., and Rapoport A. Familial hypocalciuric hypercalcemia: mild expression of the gene in heterozygotes and severe expression in homozygotes. Am J Med 78 (1985) 15-22
192. Marx S.J., Lasker R.D., Brown E.M., Fitzpatrick L.A., Sweeney N.B., Goldbloom R.B., et al. Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism. J Clin Endocrinol Metab 62 (1986) 445-449
193. Cole D.EC., Forsythe C.R., Dooley J.M., Grantmyre E.B., and Salisbury S.R. Primary neonatal hyperparathyroidism: a devastating neurodevelopmental disorder if left untreated. J Craniofac Genet Dev Biol 10 (1990) 205-214
194. Cole D.EC., Janicic N., Salisbury S.R., and Hendy G.N. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor (CASR) gene. Am J Med Genet 71 (1997) 202-210
195. Pearce S., and Steinmann B. Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism. Clin Endocrinol 50 (1999) 691-693
196. 2+-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 56 (1995) 880-886
197. Kobayashi M., Tanaka H., Tsuzuki K., Tsuzuki M., Igaki H., Ichinose Y., et al. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 82 (1997) 2716-2719
198. 2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99 (1997) 88-96
199. Kovacs C.S. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 86 (2001) 2344-2348
200. Pagan Y.L., Hirschhorn J., Yang B., D'Souza-Li L., Majzoub J.A., and Hendy G.N. Maternal activating mutation of the calcium-sensing receptor: implications for calcium metabolism in the neonate. J Pediatr Endocrinol Metab 17 (2004) 673-677
201. Chou Y.H., Brown E.M., Levi T., Crowe G., Atkinson A.B., Arnqvist H., et al. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet 1 (1992) 295-300
202. Heath III H., Jackson C.E., Otterud B., and Leppert M.F. Genetic linkage analysis of familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 53 (1993) 193-200
203. Pearce S.HS., Trump D., Wooding C., Besser G.M., Chew S.L., Grant D.B., et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96 (1995) 2683-2692
204. McMurtry C.T., Schranck F.W., Walkenhorst D.A., Murphy W.A., Kocher D.B., Teitelbaum S.L., et al. Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia. Am J Med 93 (1992) 247-258
205. Trump D., Whyte M.P., Wooding C., Pang J.T., Pearce S.HS., Kocher D.B., et al. Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH. Hum Genet 96 (1995) 183-187
206. ok), to chromosome 19q13. Am J Hum Genet 64 (1999) 189-195
207. Hendy G.N., and Cole D.EC. Parathyroid disorders. In: Rimoin D.L., Connor J.M., Pyeritz R.E., and Korf B.R. (Eds). Principles and practice of medical genetics. 5th ed (2007), Churchill Livingstone, London 1951-1979
208. Datta R., Waheed A., Shah G.N., and Sly W.S. Signal sequence mutation in autosomal dominant form of hypoparathyroidism induces apoptosis that is corrected by a chemical chaperone. Proc Natl Acad Sci USA 104 (2007) 19989-19994
209. Mannstadt M., Bertrand G., Muresan M., Weryha G., Leheup B., Pulusani S.R., et al. Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. J Clin Endocrinol Metab 93 (2008) 3568-3576
210. Heath D.A. Familial hypocalcemia-not hypoparathyroidism. N Engl J Med 335 (1996) 1144-1145
211. Vargas-Poussou R., Huang C., Hulin P., Houillier P., Jeunemaitre X., Paillard M., et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 13 (2002) 2259-2266
212. Watanabe S., Fukumoto S., Chang H., Takeuchi Y., Hasegawa Y., Okazaki R., et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360 (2002) 692-694
213. Vezzoli G., Arcidiacono T., Paloschi V., Terranegra A., Biasion R., Weber G., et al. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. J Nephrol 19 (2006) 525-528
214. Hebert S.C. Bartter syndrome. Curr Opin Nephrol Hypertens 12 (2003) 527-532
215. Hendy G.N., D'Souza-Li L., Yang B., Canaff L., and Cole D.EC. Mutations in the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 16 (2000) 281-296
216. Pidasheva S., D'Souza-Li L., Canaff L., Cole D.EC., and Hendy G.N. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 24 (2004) 107-111
217. Heath III H., Odelberg S., Jackson C.E., Teh B.T., Hayward N., Larsson C., et al. Clustered inactivation mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 81 (1996) 1312-1317
218. D'Souza-Li L., Yang B., Canaff L., Bai M., Hanley D.A., Bastepe M., et al. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 87 (2002) 1309-1318
219. Bai M., Trivedi S., Kifor O., Quinn S.J., and Brown E.M. Intermolecular interaction between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci USA 96 (1999) 2834-2839
220. Wystrychowski A., Pidasheva S., Canaff L., Chudek J., Kokot F., Wiecek A., et al. Functional characterization of calcium-sensing receptor codon 227 mutations presenting either as familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism. J Clin Endocrinol Metab 90 (2005) 864-870
221. De Andrade S.C., Kohara S.K., and D'Souza-Li L. Novel mutation of the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Clin Endocrinol 65 (2006) 826-831
222. Miyashiro K., Kunii I., Manna T.D., De Menezes Filho H.C., Damiani D., Setian N., et al. Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor. J Clin Endocrinol Metab 89 (2004) 5936-5941
223. Zhang Z., Qiu W., Quinn S.J., Conigrave A.D., Brown E.M., and Bai M. Three adjacent serines in the extracellular domain of the CaR are required for l-amino acid-mediated potentiation of receptor function. J Biol Chem 277 (2002) 33727-33735
224. Hoff A.O., Cote G.J., Fritsche Jr. H.A., Qiu H., Schultz P.N., and Gagel R.F. Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cells. Neoplasia 1 (1999) 485-491
225. Cole D.EC., Yun F.HJ., Wong B.YL., Shuen A.Y., Booth R.A., Scillitani A., et al. Calcium-sensing receptor (CASR) mutations and denaturing high performance liquid chromatography (DHPLC). J Mol Endocrinol 42 (2009) 331-339
226. Kifor O., Moore Jr. F.D., Delaney M., Garber J., Hendy G.N., Butters R., et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88 (2003) 60-72
227. Pallais J.C., Kifor O., Cheri Y.B., Slovik D., and Brown E.M. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 351 (2004) 362-369
228. Makita N., Sato J., Manaka K., Shoji Y., Oishi A., Hashimoto M., et al. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci USA 104 (2007) 5443-5448
229. Brown E.M. Anti-parathyroid and anti-calcium-sensing receptor antibodies in autoimmune hypoparathyroidism. Endocrinol Metab Clin N Am 38 (2009) 437-445
230. Posillico J.T., Wortsman J., Srikanta S., Eisenbarth G.S., Mallette L.E., and Brown E.M. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res 1 (1986) 475-483
231. Li Y., Song Y.H., Rais N., Connor E., Schatz D., Muir A., et al. Autoantibodies to the extracellular domain of the calcium-sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97 (1996) 910-914
232. Kifor O., McElduff A., Leboff M.S., Moore Jr. F.D., Butters R., Gao P., et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathroidism. J Clin Endocrinol Metab 89 (2004) 548-556
233. Goswami R., Brown E.M., Kochupillai N., Gupta N., Rani R., Kifor O., et al. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol 150 (2004) 9-18
234. Mayer A., Ploix C., Orgiazzi J., Desbos A., Moreira A., Vidal H., et al. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab 89 (2004) 4484-4488
235. Gavalas N.G., Kemp E.H., Krohn K.JE., Brown E.M., Watson P.F., and Weetman A.P. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 92 (2007) 2107-2114
236. Scillitani A., Guarnieri V., De Geronimo S., Muscarella L.A., Battista C., D'Agruma L., et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 89 (2004) 5634-5638
237. Scillitani A., Guarnieri V., Battista C., De Geronimo S., Muscarella L.A., Chiodini I., et al. Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. J Clin Endocrinol Metab 92 (2007) 277-283
238. Cole D.EC., Peltekova V.D., Rubin L.A., Hawker G.A., Vieth R., Liew C.C., et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 353 (1999) 112-115
239. Cole D.E., Vieth R., Trang H.M., Wong B.Y., Hendy G.N., and Rubin L.A. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol Genet Metab 72 (2001) 168-174
240. Lorentzon M., Lorentzon R., Lerner U.H., and Nordström P. Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Eur J Endocrinol 144 (2001) 257-261
241. Marz W., Seelhorst U., Wellnitz B., Tiran B., Obermayer-Pitsch B., Renner W., et al. Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality. J Clin Endocrinol Metab 92 (2007) 2363-2369
242. Kelly C., Gunn I.R., Gaffney D., and Devgun M.S. Serum calcium, urine calcium and polymorphisms of the calcium-sensing receptor gene. Ann Clin Biochem 43 (2006) 503-506
243. Miedlich S., Lamesch P., Mueller A., and Paschke R. Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism. Eur J Endocrinol 145 (2001) 421-427
244. Yamauchi M., Sugimoto T., Yamaguchi T., Yano S., Kanzawa M., Kobayashi A., et al. Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism. Clin Endocrinol (Oxf) 55 (2001) 373-379
245. Cetani F., Borsari S., Vignali E., Pardi E., Picone A., Cianferotti L., et al. Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism. J Endocrinol Invest 25 (2002) 614-619
246. Bollerslev J., Wilson S.G., Dick I.M., Devine A., Dhaliwal S.S., and Prince R.L. Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women. Calcif Tissue Int 74 (2004) 12-17
247. Petrucci M., Scott P., Ouimet D., Trouvé M.L., Proulx Y., Valiquette L., et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int 58 (2000) 38-42
248. Young R., Wu F., Van de Water N., Ames R., Gamble G., and Reid I.R. Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women. J Clin Endocrinol Metab 88 (2003) 697-700
249. Harding B., Curley A.J., Hannan F.M., Christie P.T., Bowl M.R., Turner J.J., et al. Functional characterization of calcium-sensing receptor polymorphisms and absence of association with indices of calcium and bone mineral density. Clin Endocrinol 65 (2006) 598-605
250. Tsukamoto K., Orimo H., Hosoi T., Miyao M., Ota N., Nakajima T., et al. Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus. Calcif Tissue Int 66 (2000) 181-183
251. Lips M.A., Syddall H.E., Gaunt T.R., Rodriguez S., Day I.N., Cooper C., et al. Interaction between birthweight and polymorphism in the calcium-sensing receptor gene indetermination of adult bone mass: the Hertfordshire cohort study. J Rheumatol 34 (2007) 769-775
252. Katsumata K., Nishizawa K., Unno A., Fujita Y., and Tokita A. Association of gene polymorphisms and bone density in Japanese girls. J Bone Miner Res 20 (2002) 164-169
253. Takacs I., Speer G., Bajnok E., Tabak A., Nagy Z., Horvath C., et al. Lack of association between calcium-sensing receptor gene A986S polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 30 (2002) 849-852
254. Cetani F., Pardi E., Borsari S., Vignali E., Dipollina G., Braga V., et al. Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women. Eur J Endocrinol 148 (2003) 603-607
255. Lau H.H., Ng M.Y., Cheung W.M., Paterson A.D., Sham P.C., Luk K.D., et al. Assessment of linkage and association of 13 genetic loci with bone mineral density. J Bone Miner Metab 24 (2006) 226-234
256. Cole D.EC., Trang H.M., Vieth R., Peltekova V.D., Pierratos A., Wong B.YL., et al. Calcium excretion is independently associated with common polymorphisms of the vitamin D receptor (VDR) and calcium-sensing receptor (CASR) genes in a nephrolithiasis population. Bone 23S (1998) T195
257. Corbetta S., Eller-Vainicher C., Filopanti M., Saeli P., Vezzoli G., Arcidiacono T., et al. R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur J Endocrinol 155 (2006) 687-692
258. Vezzoli G., Tanini A., Ferrucci L., Soldati L., Bianchin C., Franceschelli F., et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 13 (2002) 2517-2523
259. Vezzoli G., Terranegra A., Arcidiacono T., Biasion R., Coviello D., Syren M.L., et al. R990G polymorphism of calcium-sening receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 71 (2007) 1155-1162
260. Tobin M.D., Tomaszewski M., Braund P.S., Hajat C., Raleigh S.M., Palmer T.M., et al. Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension 51 (2008) 1658-1664
261. Jung J., Foroud T.M., Eckert G.J., Flury-Wetherill L., Edenberg H.L., Xuei X., et al. Association of the calcium-sensing receptor gene with blood pressure and urinary calcium in African-Americans. J Clin Endocrinol Metab 94 (2009) 1042-1048
262. Speer G., Cseh K., Mucsi K., Takacs I., Dworak O., Winkler G., et al. Calcium-sensing receptor A986S polymorphism in human rectal cancer. Int J Colorectal Dis 17 (2002) 20-24
263. Peters U., Chatterjee N., Yeager M., Chanock S.J., Schoen R.E., McGlynn K.A., et al. Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 13 (2004) 2181-2186
264. Dong L.M., Ulrich C.M., Hsu L., Duggan D.J., Benitez D.S., White E., et al. Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol Biomarkers Prev 17 (2008) 2755-2765
265. Muddana V., Lamb J., Greer J.B., Elinoff B., Hawes R.H., Cotton P.B., et al. Association between calcium-sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal1 type and alcohol. World J Gastroenterol 14 (2008) 4486-4491
266. Conley Y.P., Mukherjee A., Kammerer C., Dekosky S.T., Kamboh M.I., Finegold D.N., et al. Evidence supporting a role for the calcium-sensing receptor in Alzheimer disease. Am J Med Genet B Neuropsychiatr Genet 150B (2009) 703-709
267. Soie Y.L., Karperien M., Bakker B., Breuning M.H., Hendy G.N., and Papapoulos S.E. Familial benign hypercalcemia (FBH) with age-associated hypercalciuria and a missense mutation in the calcium-sensing receptor (CaSR) expands the spectrum of the syndrome towards primary hyperparathyroidism. J Bone Miner Res 14s1 (1999) S447 SU062
268. Simonds W.F., James-Newton L.A., Agarwal S.K., Yang B., Skarulis M.C., Hendy G.N., et al. Familial isolated hyperparathyroidism. Clinical and genetic characteristics of 36 kindreds. Medicine 81 (2002) 1-26
269. Warner J., Epstein M., Sweet A., Singh D., Burgess J., Stranks S., et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41 (2004) 155-160
270. 2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80 (1995) 3107-3110
271. Thompson D.B., Samowitz W.S., Odelberg S., Davis R.K., Szabo J., and Heath III H. Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab 80 (1995) 3377-3380
272. Cetani F., Pinchera A., Pardi E., Cianferotti L., Vignali E., Picone A., et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 14 (1999) 878-882
273. Hendy G.N., and Arnold A. Molecular basis of PTH overexpression. In: Bilezikian J.P., Martin T.J., and Raisz L.G. (Eds). Principles of Bone Biology. 3rd ed (2008), Academic Press, San Diego 1311-1326
274. Gogusev J., Duchambon P., Hory B., Giovannini M., Goureau Y., Sarfait E., et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51 (1997) 328-336
275. Kremer R., Bolivar I., Goltzman D., and Hendy G.N. Influence of calcium and 1, 25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125 (1989) 935-941
276. Yao J.J., Bai S., Karnauskas A.J., Bushinsky D.A., and Favus M.J. Regulation of renal calcium receptor gene expression by 1, 25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16 (2005) 1300-1308
277. Bai S., and Favus M. Vitamin D and calcium receptors: links to hypercalciuria. Curr Opin Nephrol Hypertens 15 (2006) 381-385
278. Chakravarti B., Dwivedi S.K.D., Mithal A., and Chattopadhyay N. Calcium-sensing receptor in cancer: good cop or bad cop?. Endocrine 35 (2008) 271-284
279. Saidak Z., Mentaverri R., and Brown E.M. The role of the calcium-sensing receptor in the development and progression of cancer. Endocrine Rev 30 (2009) 178-195
280. 2+ and 1, 25-dihydroxyvitamin D. Cancer Res 65 (2005) 493-498
281. Sanders J.L., Chattopadhyay N., Kifor O., Yamaguchi T., Butters R.R., and Brown E.M. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141 (2000) 4357-4364
282. Sanders J.L., Chattopadhyay N., Kifor O., Yamaguchi T., and Brown E.M. Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 281 (2001) E1267-E1274
283. Yano S., Macleod R.J., Chattopadhyay N., Tfelt-Hansen J., Kifor O., Butters R.R., et al. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation. Bone 35 (2004) 664-672
284. Zaloga G.P. Hypocalcema in critically ill patients. Crit Care Med 20 (1992) 251-262
285. Zivin J.R., Gooley T., Zager R.A., and Ryan M.J. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis 37 (2001) 689-698
286. Drüeke T.B., and Ritz E. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. Clin J Am Soc Nephrol 4 (2009) 234-241
287. Wetmore J.B., and Quarles L.D. Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?. Nat Clin Pract Nephrol 5 (2009) 24-33
288. Khan A., Grey A., and Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94 (2009) 373-381
289. Nemeth E.F. Drugs acting on the calcium receptor. Calcimimimetics and calcilytics. In: Bilezikian J.P., Martin T.J., and Raisz L.G. (Eds). Principles of Bone Biology. 3rd ed (2008), Academic Press, San Diego 1711-1735
290. Timmers H.JLM., Karperien M., Hamdy N.AT., De Boer H., and Hermus A.RMM. Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. J Int Med 260 (2006) 177-182
291. Festen-Spanjer B., Haring C.M., Koster J.B., and Mudde A.H. Correction of hypercalcemia by cinacalcet in familial hypocalciuric hypercalcemia. Clin Endocrinol 68 (2007) 321-325
292. 2+-sensing receptor gene. J Clin Endocrinol Metab 80 (1995) 2594-2598
293. Alvarez-Hernandez D., Santamaria I., Rodriguez-Garcia M., Iglesias P., Delgado-Lillo R., and Cannata-Andia J.B. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with uncommon parathyroid hormone polymorphisms. J Mol Endocrinol 31 (2003) 255-262
294. Arunchaiya S., Pollak M.R., Seidman C.A., Pinhas-Hamiel O., Welch T.R., Tsang R.C., et al. Marked hypercalcemia in a five month old male associated with heterozygous point mutation in the calcium-sensing receptor gene. Prog & Abs 80th Ann Meet Endo Soc (1998) 493 Abs. P3-535
295. 2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 5 (1996) 601-606
296. Burren C.P., Curley A., Christie P., Rodda C.P., and Thakker R.V. A family with autosomal dominant hypocalcaemia with hypercalciuria (ADHH): mutational analysis, phenotypic variability and treatment challenges. J Pediatr Endocrinol Metab 18 (2005) 689-699
297. Burski K., Torjussen B., Paulsen A.Q., Boman H., and Bollerslev J. Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: coincidence or causality?. J Clin Endocrinol Metab 87 (2002) 1015-1016
298. Chikatsu N., Fukumoto S., Suzawa M., Tanaka Y., Takeuchi Y., Takeda S., et al. An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor. Clin Endocrinol 50 (1999) 537-543
299. Chikatsu N., Watanabe S., Takeuchi Y., Muraosa Y., Sasaki S., Oka Y., et al. A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene. Endocrine J 50 (2003) 91-96
300. Chou Y.H., Pollak M.R., Brandi M.L., Toss G., Arnqvist H., Atkinson A.B., et al. Mutations of the human Ca(2+)-sensing receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet 56 (1995) 1075-1079
301. Christie P.T., Curley A.J., Harding B., Bowl M.R., Turner J.JO., Cappucco F.P., et al. An activating calcium sensing receptor mutation associated with normocalcemic (idiopathic) hypercalciuric nephrolithiasis. J Bone Miner Res 17s1 (2002) S127 Abs 1008
302. Christie P., Curley A., Nesbit M.A., Harding B., Bowl M., and Thakker R. Characterization of 25 calcium-sensing receptor mutations in disorders of calcium homeostasis. Society for Endocrinology BES 2007 Endocrine Abstracts 13, P1 (2007)
303. Cole D.R., Soule S., Raizis A., and George P. Hypocalcemia and a novel calcium-sensing receptor activating mutation. Ann Sci Meet Royal Australasian College Physicians 2005 Int Med J (Suppl.) 35 (2005) A68
304. Conley Y.P., Finegold D.N., Peters D.G., Cook J.S., Oppenheim D.S., and Ferrell R.E. Three novel activating mutations in the calcium-sensing receptor for autosomal dominant hypocalcemia. Mol Genet Metab 71 (2000) 591-598
305. Defrance-Faivre F., Odou M.-F., Porchet N., Weill J., Guedj A., Cardot-Bauters C., et al. Molecular analysis of the calcium-sensing receptor (CaSR) gene in 40 patients suspected to have familial hypocalciuric hypercalcemia (FHH). European Congress of Endocrinology 2008 Endocrine Abstracts 16, OC4.7 (2008)
306. De Luca F., Ray K., Mancilla E.E., Fan G.F., Winer K.K., Gore P., et al. Sporadic hypoparathyroidism caused by de novo gain-of-function mutations of the Ca(2+)-sensing receptor. J Clin Endocrinol Metab 82 (1997) 2710-2715
307. Demedts M., Lissens W., Wuyts W., Matthus G., Thomeer M., and Bouillon R. A new missense mutation in the CASR gene in familial interstitial lung disease with hypocalciuric hypercalcemia and defective granulocyte function. Am J Resp Crit Care Med 177 (2008) 558-559
308. th Ann Mtg Endo Soc 2005 Abs P2-607 (2005)
309. Dreimane D., Hendy G.N., Alon U., and Geffner M. Normalization of serum calcium, phosphorus, and magnesium with homeopathic PTH in a child with hypocalcemic hypercalciuria (HCHC) and a mutation of the calcium-sensing receptor gene. Prog Abs 83rd Ann Mtg Endo Soc 2001 Abs P3-125 (2001)
310. D'Souza-Li L., Canaff L., Janicic N., Cole D.EC., and Hendy G.N. An acceptor slice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Hum Mutat 18 (2001) 411-421
311. D'Souza-Li L., Silva M.BD., Grande M.T., Carvalho D., and Guerra G. Two novel mutations in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Bone Miner Res 17s1 (2002) M438
312. Ekhzaimy A., Wing S.S., and Hendy G.N. A novel mutation in the calcium-sensing receptor (CASR) gene in a hypocalcemic patient presenting with symptoms of lupus. CDA/CSEM Professional Conference and Annual Meetings October 18-21, 2006 Abstract (2006)
313. Felderbauer P., Hoffman P., Klein W., Bulut K., Ansorge N., Epplen J.T., et al. Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis. Exp Clin Endocrinol Diabetes 113 (2005) 31-34
314. Felderbauer P., Klein W., Bulut K., Ansorge N., Dekomien G., Werner I., et al. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis?. Scand J Gastroenterol 41 (2006) 343-348
315. Fox L., Sadowsky J., Pringle K.P., Kidd A., Murdoch J., Cole D.EC., et al. Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant. Pediatrics 120 (2007) e1350-e1354
316. Fukumoto S., Chikatsu N., Okazaki R., Takeuchi Y., Tamura Y., Murakami T., et al. Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia. Diagn Mol Pathol 10 (2001) 242-247
317. Haag C., Schulze E., Lorenz A., Frank-Raue K., and Raue F. Novel mutations of the calcium-sensing receptor in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. Prog & Abs 87th Ann Meet Endo Soc 2005 P2-407 (2005)
318. Hannan F., Nesbit M.A., Christie P., Bex M., Bouillon R., and Thakker R. A novel homozygous inactivating mutation, Pro339Thr, of the calcium-sensing receptor is associated with isolated primary hyperparathyroidism. Endo Abstracts 2007 13, OC9 (2007)
319. Hendy G.N., Minutti C., Canaff L., Pidasheva S., Yang B., Nouhi Z., et al. Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene. J Clin Endocrinol Metab 88 (2003) 3674-3681
320. Henn M., Wygoda S., Nagel M., and Richter T. Benigne familiare hypokalziurische hyperkalzamie (FHH)-neue mutation des calcium sensing receptors (CaSR) bei einem 7-juhrigen madchen. Jahrestagung der Sachsisch-Thuringischen Gesellschaft fur Kinder- und Jugendmedizin und Kinderchirurgie am 04. und 05. April 2008 in Chenitz Abstract P29 (2008)
321. Hirai H., Nakajima S., Miyauchi A., Nishimura K., Shimizu N., Shima M., et al. A novel activating mutation (C129S) in the calcium-sensing receptor in a Japanese family with autosomal dominant hypocalcemia. J Hum Genet 46 (2001) 41-44
322. Hu J., Mora S., Colussi G., Proverbio M.C., Jones K., Bolzoni L., et al. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain. J Bone Miner Res 17 (2002) 1461-1469
323. Hu J., Mora S., Weber G., Zamproni I., Proverbio M.C., and Spiegel A.M. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor. J Bone Miner Res 19 (2004) 578-586
324. Inoue D., Saika M., Ikeda Y., and Matsumoto T. Successful treatment of hypoparathyroidism caused by a novel calcium-sensing receptor mutation with thiazide diuretics and low dose alfacalcidol. Bone 23S (1998) S382
325. Jap T.-S., Wu Y.C., Jenq S.F., and Won G.S. A novel mutation in the calcium-sensing receptor gene in a Chinese subject with persistent hypercalcemia and hypocalciuria. J Clin Endocrinol Metab 86 (2001) 13-15
326. Kapoor A., Satishchandra P., Ratnapriya R., Reddy R., Kadandale J., Shankar S.K., et al. An idiopathic epilepsy syndrome linked to 3q13.3-q21 and missense mutations in the extracellular calcium sensing receptor gene. Ann Neurol 64 (2008) 158-167
327. Lam C.-W., Lee K.-F., Chan A.O.-K., Poon P.M.-K., Law T.-K., and Tong S.-F. Novel missense mutation in the CASR gene in a Chinese family with familial hypocalciuric hypercalcemia. Clin Chim Acta 360 (2005) 167-172
328. Leech C., Lohse P., Stanojevic V., Lechner A., Goke B., and Spitzweg C. Identification of a novel inactivating R465Q mutation of the calcium-sensing receptor. Biochem Biophys Res Commun 342 (2006) 996-1002
329. Lienhardt A., Bai M., Lagarde J., Kottler M., and Farhid N.R. New mutation of the calcium-sensing receptor gene associated with isolated hypoparathyroidism. Prog & Abs 83rd Ann Meet Endo Soc 2001 P3-123 (2001)
330. Lienhardt A., Garabedian M., Bai M., Sinding C., Zhang Z., Lagarde J.P., et al. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab 85 (2000) 1695-1702
331. Lienhardt A., Young J., Largarde J., Bai M., Kottler M., Schalson G., et al. New type of calcium-sensing receptor mutation leading to isolated hypoparathyroidism. Prog & Abstr Endo Soc 83rd Ann Meet 2001 P1-504 (2001)
332. Livadariu E., Rydlewski C., Hamoir E., Betea D., Burlacu C., Daly A.F., et al. Two novel mutations of the calcium sensing receptor gene. Prog & Abs Endo Soc 90th Ann Meet 2008 P1-568 (2008)
333. 2+-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Hum Genet 98 (1996) 129-133
334. Ma R.C., Lam C.W., So W.Y., Tong P.C., Cockram C.S., and Chow C.C. A novel CASR gene mutation in an octogenarian with asymptomatic hypercalcemia. Hong Kong Med J 14 (2008) 226-228
335. Mahto R., Tahraru A., MacLeod A., and Thakker R.V. Familial hypocalciuric hypercalcemia (FHH) caused by P748L mutation in the calcium sensing receptor (CaSR) gene. European Congress of Endocrinology 2006 Endocrine Abstracts 11 P163 (2006)
336. Mancilla E.E., De Luca F., Ray K., Winer K.K., Fan G.F., and Baron J. A Ca(2+)-sensing receptor mutation causes hypoparathyroidism by increasing receptor sensitivity to Ca2+ and maximal signal transduction. Pediatr Res 42 (1997) 443-447
337. Marcocci C., Borsari S., Pardi E., Dipollina G., Giacomelli T., Pinchera A., et al. Familial hypocalciuric hypercalcemia in a woman with metastatic breast cancer: a case report of mistaken identity. J Clin Endocrinol Metab 88 (2003) 5132-5136
338. Mittelman S.D., Hendy G.N., Fefferman R.A., Canaff L., Mosesova I., Cole D.EC., et al. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. J Clin Endocrinol Metab 91 (2006) 2474-2479
339. Miyashiro K., Kasamatsu T.S., Steinmetz L., de Menezes Filho H.C., Damiani D., Setian N., et al. Identification and functional analysis of a novel inactivating mutation (A804D) of the calcium-sensing receptor gene. Clin Endocrinol 61 (2004) 780-782
340. Mora S., Zamproni I., Proverbio M.C., Bozzetti V., Chiumello G., and Weber G. Severe hypocalcemia due to a de novo mutation in the fifth transmembrane domain of the calcium-sensing receptor. Am J Med Genet 140A (2006) 98-101
341. Murugaian E.E., Premkumar R.M., Radhakrishnan L., and Vallath B. Novel mutations in the calcium-sensing receptor gene in tropical chronic pancreatitis in India. Scand J Gastroenterol 43 (2008) 117-121
342. Nakae J., Shinohara N., Tanahashi Y., Murashita M., Abe S., Hasegawa Y., et al. New mutations of calcium-sensing receptor gene in two Japanese patients with sporadic hypoparathyroidism with hypercalciuria. XVth International Symposium of Endocrinology and Development (1997) Horm. Res 48, 1997 Abstract 798, Paris, France
343. 2+-sensing receptor gene in familial hypocalciuric hypercalcemia. Endocrine 15 (2001) 277-282
344. Nissen P.H., Christensen S.E., Heickendorff L., Brixen K., and Moekilde L. Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab 92 (2007) 4373-4379
345. Nyweide K., Feldman K.W., Gunther D.F., Done S., Lewis C., and Van Eenwyk C. Hypocalciuric hypercalcemia presenting as neonatal rib fractures. Pediatr Emerg Care 22 (2006) 722-724
346. Obermannova B., Banghova K., Sumnik Z., Dvorakova H.M., Betka J., Fenci F., et al. Unusually severe phenotype of neonatal primary hyperparathyroidism due to a heterozygous inactivating mutation in the CASR gene. Eur J Pediatr 168 (2009) 569-573
347. Okazaki R., Chikatsu N., Nakatsu M., Takeuchi Y., Alima M., Miki J., et al. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. J Clin Endocrinol Metab 84 (1999) 363-366
348. Ono Y., Oda N., Ishihara S., Shimomura A., Hayakawa N., Suzuki A., et al. Insulinoma cell calcium-sensing receptor influences insulin secretion in a case with concurrent familial hypocalciuric hypercalcemia and malignant metastatic insulinoma. Eur J Endocrinol 159 (2008) 81-89
349. Poppe K., Karmali R., Lissens W., Vanhaelst L., Liebaers I., Fuss M., et al. Citrate infusion test in the diagnosis of hypocalcemia due to a mutation in the calcium-sensing receptor gene. Eur J Intern Med 13 (2002) 276-279
350. Rajguru M., Bedu A., Magdelaine C., Bai M., Aujuard Y., and Lienhardt A. Neonatal primary hyperparathyroidism due to a new calcium sensing receptor mutation. Pediatr Res 49 (2001) P3-294
351. Ryan J., Thorne J., Hoashi S., Green A., and Powell D. A novel calcium-sensing receptor gene mutation in a family with an extensive history of familial hypocalciuric hypercalcemia. British Endocrine Societies Joint Meeting 2005 Endocrine Abstracts P, P183 (2005)
352. Sanda S., Schlingmann K.P., and Newfield R.S. Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous magnesium infusion. J Pediatr Endocrinol Metab 21 (2008) 385-391
353. Sarli M., Fradinger E., and Zanchetta J. Hypocalciuric hypercalcemia due to de novo mutation of the calcium-sensing receptor. Medicina (Buenos Aires) 64 (2004) 337-339
354. Sato K., Hasegawa Y., Nakae J., Nanao K., Takahashi I., Tajima T., et al. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab 87 (2002) 3068-3073
355. 2+-sensing receptor gene in three Danish families. Scand J Clin Lab Invest 60 (2000) 221-227
356. Shiohara M., Mori T., Bai M., Brown E.M., Watanabe T., and Yasuda T. A novel gain-of-function mutation (F821L) in the transmembrane domain of calcium-sensing receptor is a cause of severe sporadic hypoparathyroidism. Eur J Pediatr 163 (2004) 94-98
357. Sinha S.K., Ten S., and Hendy G.N. Novel inactivating mutation of the calcium-sensing receptor associated with familial hypocalciuric hypercalcemia. Pediatric Academic Societies Annual Meeting. Honolulu Hawaii May 3-6, 2008 Abstract (2008)
358. Speer G., Toth M., Niller H.-H., Salamon D., Takacs I., Miheller P., et al. Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia. Exp Clin Endocrinol Diabetes 111 (2003) 486-490
359. Stock J.L., Brown R.S., Baron J., Coderre J.A., Mancilla E., De Luca F., et al. Autosomal dominant hypoparathyroidism associated with short stature and premature osteoarthritis. J Clin Endocrinol Metab 84 (1999) 3036-3040
360. Suzuki M., Aso T., Sato T., Michimata M., Kazama I., Saiki H., et al. A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection. Clin Nephrol 63 (2005) 481-486
361. Tan Y.M., Cardinal J., Franks A.H., Mun H.C., Lewis N., Harris L.R., et al. Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor. J Clin Endocrinol Metab 88 (2003) 605-610
362. Toke J., Czirjak G., Patocs A., Enyedi B., Gergics P., Csakvary V., et al. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene. Clin Endocrinol 67 (2007) 385-392
363. Uckun-Kitapci A., Underwood L.E., Zhang J., and Moats-Staats B. A novel mutation (E767K) in the second extracellular loop of the calcium-sensing receptor in a family with autosomal dominant hypocalcemia. Am J Med Genet 132A (2005) 125-129
364. Vigouroux C., Bourut C., Guerci B., Ziegler O., Magre J., Capeau J., et al. A new missense mutation in the calcium-sensing receptor in familial benign hypercalcemia associated with lipoatrophy and insulin resistant diabetes. Clin Endocrinol 53 (2000) 393-398
365. Waller S., Kurzawinski T., Spitz L., Thakker R., Cranston T., Pearce S., et al. Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 163 (2004) 589-594
366. Ward B.K., Cameron F.J., Magno A.L., McDonnell C.M., Stuckey B.GA., and Ratajczak T. A novel homozygous deletion in the calcium-sensing receptor ligand-binding domain associated with neonatal severe hyperparathyroidism. J Pediatr Endocrinol Metab 19 (2006) 93-100
367. Ward B.K., Magno A.L., Davis E.A., Hanyaloglu A.C., Stuckey B.GA., Burrows M., et al. Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 89 (2004) 3721-3730
368. Ward B.K., Magno A.L., Blitvitch B.J., Rea A.J., Stuckey B.GA., Walsh J.P., et al. Novel mutations in the calcium-sensing receptor gene associated with biochemical and function differences in familial hypocalciuric hypercalcemia. Clin Endocrinol 64 (2006) 580-587
369. 2+-sensing receptor sensing receptor gene associated with familial hypocalciuric hypercalcemia. Hum Mutat 10 (1997) 233-235
370. Watanabe T., Bai M., Lane C.R., Matsumoto S., Minamitani K., Minagawa M., et al. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor. J Clin Endocrinol Metab 83 (1998) 2497-2502
371. Woo S.I., Song H., Song K.E., Kim D.J., Lee K.W., Kim S.J., et al. A case report of familial benign hypocalciuric hypercalcemia: a mutation in the calcium-sensing receptor gene. Yonsei Med J 47 (2006) 255-258
372. Yamamoto M., Akatsu T., Nagase T., and Ogata E. Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?. J Clin Endocrinol Metab 85 (2000) 4583-4591
373. Yamauchi M., Sugimoto T., Yamaguchi T., Yano S., Wang J., Bai M., et al. Familial hypocalciuric hypercalcemia caused by a R648stop mutation in the calcium sensing receptor gene. J Bone Miner Res 17 (2002) 2174-2182
374. 2+ receptor. FEBS Lett 448 (1999) 180-184
375. Den Dunnen J.T., and Antonarakis S.E. Nomenclature for the description of human sequence variations. Hum Genet 109 (2001) 121-124